 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
4/17/24 Acrivon Therapeutics, Inc. S-3 4:313K Donnelley … Solutions/FA
3/29/24 Acrivon Therapeutics, Inc. S-8 3/29/24 4:76K Donnelley … Solutions/FA
3/28/24 Acrivon Therapeutics, Inc. 10-K 12/31/23 78:91M Donnelley … Solutions/FA
3/21/24 Mineralys Therapeutics, Inc. S-3 6:1.8M Workiva Inc Wde… FA01/FA
3/21/24 Mineralys Therapeutics, Inc. 10-K 12/31/23 65:20M Workiva Inc Wde… FA01/FA
3/7/24 Werewolf Therapeutics, Inc. S-8 3/7/24 4:116K
3/7/24 Werewolf Therapeutics, Inc. 10-K 12/31/23 84:7.8M
3/1/24 89bio, Inc. 10-K 12/31/23 69:17M Donnelley … Solutions/FA
12/1/23 Acrivon Therapeutics, Inc. S-3 7:1.1M Donnelley … Solutions/FA
8/11/23 Acrivon Therapeutics, Inc. S-8 8/11/23 5:79K Donnelley … Solutions/FA
5/23/23 89bio, Inc. S-3ASR 5/23/23 5:732K Donnelley … Solutions/FA
5/10/23 iTeos Therapeutics, Inc. S-3 6:2.9M Donnelley … Solutions/FA
4/25/23 89bio, Inc. S-3ASR 4/25/23 4:216K Donnelley … Solutions/FA
3/29/23 Acrivon Therapeutics, Inc. S-8 3/29/23 4:72K Donnelley … Solutions/FA
3/28/23 Acrivon Therapeutics, Inc. 10-K 12/31/22 91:108M Donnelley … Solutions/FA
3/23/23 Werewolf Therapeutics, Inc. S-8 3/23/23 5:121K
3/23/23 Werewolf Therapeutics, Inc. 10-K 12/31/22 83:7.5M
3/15/23 Mineralys Therapeutics, Inc. 10-K 12/31/22 7:11M
3/15/23 iTeos Therapeutics, Inc. S-8 3/15/23 4:156K Donnelley … Solutions/FA
3/15/23 iTeos Therapeutics, Inc. 10-K 12/31/22 84:12M Donnelley … Solutions/FA
| ____________ | | ¹ | Filing/Form Types: | | 10-K | Annual Report — Form 10-K. | | S-3 | Registration Statement – Securities for a Transaction — Form S-3. | | S-3ASR | Automatic Shelf Registration Statement by a Well-Known Issuer — Form S-3. | | S-8 | Registration Statement – Securities for an Employee Benefit Plan — Form S-8. |
|
